### **Overview** Veerhealth Care Limited, formerly known as Niyati Leasing Limited, transitioned from an investment and finance company to a full-fledged pharmaceutical and personal care manufacturer in 2013. Headquartered in Vapi, Gujarat, the company operates a state-of-the-art 90,000 sq. ft. manufacturing facility compliant with international quality standards including **Ayurvedic GMP, Cosmetic GMP, ISO 9001:2015**, and **USFDA regulations**. The company specializes in **pure vegetarian, Ayurvedic, herbal, and natural personal care, oral care, and cosmetic-grade products**, positioning itself as a key player in India’s growing wellness and global healthcare export markets. The company’s product portfolio includes toothpaste, shampoos, conditioners, lip balms, body scrubs, shower gels, lotions, creams, and over-the-counter (OTC) drug products. It serves both domestic and international markets through **contract manufacturing (private/white-label), branded offerings under ‘Ayuveer’**, and **direct exports**. --- ### **Strategic Developments & Key Milestones (2023 – Nov 2025)** #### **November 2025: New Private-Label Order from Leading FMCG Brand** - Veerhealth Care secured a **new private-label manufacturing order** from one of India’s top FMCG companies for a **personal care product line**. - This order marks a significant business expansion and is expected to **boost turnover** substantially in the coming quarters. #### **August – November 2025: Regulatory & Manufacturing Expansion** - **USFDA Approvals**: - Successfully passed USFDA audits and received **clearance to export OTC drug products** to the United States in June 2025. - Completed formalities for **exporting medical device category products** to the U.S., placing Veerhealth among a **select group of small-cap Indian manufacturers** with dual USFDA readiness. - Assigned a **National Drug Code (NDC) Labeler Code**, enabling direct marketing of regulated products in U.S. institutional sectors. - **Plant Upgrades**: - Upgraded its Vapi facility to comply with **USFDA Current Good Manufacturing Practices (CGMP)**, enhancing credibility and access to high-value export contracts. #### **August 2025: Backward Integration via VEER PLAST Launch** - Launched **VEER PLAST**, a dedicated **plastic molding division** to ensure **in-house production of packaging** through **blow molding and injection molding**. - Supports **backward integration**, reduces dependency on third-party suppliers, improves cost efficiency, and strengthens supply chain resilience. #### **June – August 2025: Entry into Institutional & Hospital Care Segment** - Formed a new **Hospital Care Division** in partnership with a leading medical equipment manufacturer. - Offers **ventilators, defibrillators, infusion pumps, syringe pumps**, and accessories to **government organizations and hospitals**. - First commercial supplies have been delivered, with plans to scale to **₹9–10 crores in annual revenue** and **10–15% EBITDA margins**. - Requires an internal investment of **₹1 crore (Rs. 100 lakhs)**. #### **June – August 2025: Global Expansion & Export Growth** - Resumed export shipments to the U.S. after resolving earlier disruptions linked to USFDA inspections. - Dispatched **three Full Container Load (FCL)** shipments; targeting **4–5 FCLs monthly**. - Secured high-value export orders: - **₹0.74 crore** oral care order (fulfilled within 30 days). - **₹0.48 crore** skincare and face care order. - Multiple past orders from U.S. institutional clients totaling over **₹3.72 crore** in late 2024. - **$16.5 crore (₹16.5 crore)** major export order from a U.S. institutional supplier (May 2024), following successful sample delivery – a **strategic entry into the U.S. correctional and detention supply chain**. #### **December 2024: Russian Market Expansion** - Approved by a **major Russian corporate group** (with retail presence in Metro Cash & Carry and Auchan) to **manufacture and export oral care products** to Russia. - Marks a **new geographic diversification** and entry into CIS markets. #### **August 2024: Manufacturing Expansion** - Acquired **27,451 sq. ft. of land** adjacent to existing Vapi facility, bringing total plot area to **58,623 sq. ft.** and built-up area to **90,000 sq. ft.** - New **CGMP-compliant lines** for body care, skincare, and high-capacity filling are operational. - Investments include in-house **plastic molding capabilities** to support backward integration and reduce costs. #### **August 2024: Repeat Export Orders** - Received a **repeat order of $101,680 (~₹84 lakhs)** for a new toothpaste variant from a U.S. institutional client. - All product variants for this client are now being supplied by Veerhealth. #### **June – Sep 2024: E-Commerce & Branded Growth** - **Ayuveer brand** launched on **Nykaa (Jun 2024)** and later on **Myntra (Jun 2025)**, joining existing platforms: **Amazon, Flipkart, Glowroad, and Jiomart**. - This omnichannel digital presence is driving **increased brand visibility and revenue growth**. - Online sales currently contribute **10–12% of total revenue**, with plans to grow branded segment to **35% of total revenue by FY2025–26** (from 15% in 2024). --- ### **Business Model & Revenue Streams** | Stream | Share (FY2024-25) | Outlook | |--------|-------------------|--------| | **Contract Manufacturing (Private/White-Label)** | 55% | Core strength; growing via new FMCG & institutional deals | | **Export Business** | 30% | Steady growth driven by U.S., East Africa, North Africa, and Russia | | **Branded Sales (Ayuveer)** | 15% → **Target 35% by FY26** | Strategic push via e-commerce and retail onboarding | - **In-house R&D**: Over **100+ products developed**, offering **custom formulations** for clients with **low MOQs (from 1,000 pieces)**. - **Product Development Led By**: - **Dr. Vinod C. Mehta (BAMS)** – 35+ years in Ayurveda. - **Dr. Rajiv Bhirud (Ph.D.)** – Expert in cosmetic and personal care formulations.